These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9841168)

  • 1. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population.
    Baglin TP; Brown K; Williamson D; Baker P; Luddington R
    Thromb Haemost; 1997 Jun; 77(6):1219. PubMed ID: 9241762
    [No Abstract]   [Full Text] [Related]  

  • 5. Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis?
    Comp PC
    Contraception; 2006 Jan; 73(1):4-5. PubMed ID: 16371288
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V Leiden mutation and venous thrombosis.
    Hatake K; Miura Y
    Lancet; 1995 Jan; 345(8942):133. PubMed ID: 7815876
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].
    Vandenbroucke JP; Briët E; Helmerhorst F; van der Meer FJ
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1067-71. PubMed ID: 7783798
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor V Leiden mutation and venous thrombosis.
    Davies KA; Ireland H; Athanassiou P; Loizou S; Lane D; Walport MJ
    Lancet; 1995 Jan; 345(8942):132-3. PubMed ID: 7815875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inferior caval thrombosis and pulmonary thromboembolism as complications due to the use of oral hormonal contraceptives].
    Koroleva IM; Dolgushina LM
    Vestn Rentgenol Radiol; 2004; (4):47-9. PubMed ID: 15626235
    [No Abstract]   [Full Text] [Related]  

  • 11. Human genetics. Bad blood by mutation.
    Majerus PW
    Nature; 1994 May; 369(6475):14-5. PubMed ID: 8164730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral contraceptives and thromboembolic complications].
    Dorph S; Jorgensen SJ
    Ugeskr Laeger; 1965 Dec; 127(50):1621-3. PubMed ID: 5868340
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptives and screening for factor V Leiden.
    Rosendaal FR
    Thromb Haemost; 1996 Mar; 75(3):524-5. PubMed ID: 8701424
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of thrombosis in patients homozygous for factor V Leiden.
    Samama MM; Trossaërt M; Horellou MH; Elalamy I; Conard J; Deschamps A
    Blood; 1995 Dec; 86(12):4700-2. PubMed ID: 8541565
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiology patient page. Factor V Leiden.
    Ornstein DL; Cushman M
    Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the etiology and treatment of venous thromboembolism.
    Comp PC
    Adv Intern Med; 1999; 44():59-89. PubMed ID: 9929705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral contraceptives increase the chance of venous thrombosis in factor V Leiden mutation].
    Huikeshoven FJ; Lotgering FK
    Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1561-2. PubMed ID: 7675138
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary vein thrombosis and pulmonary embolism possibly due to oral contraception.
    Edwards LA; Hilliard JR; Wood DE
    Can Med Assoc J; 1969 Jan; 100(2):78-80. PubMed ID: 5762476
    [No Abstract]   [Full Text] [Related]  

  • 20. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.